-  - 
Start page - 
Search - 
Start page -  / About CEFFORT AB

Map - Nordic market

 -  

The Nordic region
Sweden, Norway, Denmark, Finland and Iceland

Ceffort specialize on the Nordic region

By coordinating and managing various industry and academic networks, in addition to both national and cross-border R&D programs, Ceffort management have established good business contacts in life sciences, over the territories of Sweden, Norway, Denmark, Finland and Iceland. These valuable business relationships have been nurtured through the years and are nowadays available for further collaboration opportunities.

Life Science industry segments we collaborate within

When you look for a service provider to develop your business, Ceffort is an ideal partner. Due to our well established long term business relationships within Nordic life sciences, Ceffort can identify key service & technology providers for possible collaboration in just a few contacts within the value chains.

Our network covers the following life science segments in the Nordic region:

  • Academic and institute R&D
  • Bioanalysis
  • Bioenergy (biogas / ethanol)
  • Biomanufacturing
  • Bioprocessing
  • Biopharmaceuticals
  • Biotechnology tools
  • Cell culture
  • Diagnostics (IVD / point-of-care)
  • Distributors
  • Due diligence
  • Industrial biotechnology
  • Investments
  • Medical devices (analytical)
  • Microbial processes
  • Governmental organizations
  • Service providers (CMOs, CDMOs, CROs, specialist laboratories etc)
  • Technology developers
  • Valuations

Today, Ceffort management can refer to our good collaboration history with more than a 150 companies and up to a 1000 companies within a quick reach across the Nordic Life Science market.

Our customers work with

  • Living systems to develop or produce cell mass, biopharmaceuticals, antibodies, bioanalytical compounds, proteins, enzymes, chemicals, biogas, ethanol or other end-products
  • Development and manufacturing of biopharmaceuticals
  • Analytical development and characterization
  • Development of new technologies for use in life sciences
  • Development of advanced product purification
  • Investments in life science companies
  • Services to the Nordic market
 - Back  -    To top  -